Table of Contents Table of Contents
Previous Page  44 / 144 Next Page
Information
Show Menu
Previous Page 44 / 144 Next Page
Page Background

43

Frontken Corporation Berhad (651020-T)

ANNUAL REPORT

2016

DIRECTORS

The following directors served on the Board of the Company since the date of the last report:

Ng Wai Pin

Dr. Tay Kiang Meng

Dato’ Haji Johar Bin Murat @ Murad

Aaron Sim Kwee Lein

Dr. Jorg Helmut Hohnloser

Timo Fabian Seeberger (Alternate to Dr. Jorg Helmut Hohnloser)

DIRECTORS’ INTERESTS

According to the register of directors’ shareholdings, the interests of directors holding office at the end of the financial year

in shares in the Company and its related corporations during the financial year are as follows:

Number of ordinary shares of RM0.10 each

Balance as of

1.1.2016

Bought

Sold

Balance as

of

31.12.2016

Shares in the Company

Direct Interests

Ng Wai Pin

3,000,000

2,000,000

-

5,000,000

Dr. Tay Kiang Meng

9,404,808

-

-

9,404,808

Indirect Interest

Dr. Jorg Helmut Hohnloser

290,991,473

-

290,991,473

-

By virtue of the above directors’ interests in the shares of the Company, they are deemed to have interests in the shares of

the subsidiaries to the extent the directors have their interests.

The other directors holding office at the end of the financial year had no interests in the shares of the Company or of its

related corporations during the financial year.

DIRECTORS’ BENEFITS

Since the end of the previous financial year, no director has received or become entitled to receive any benefit (other than

a benefit included in the aggregate amount of emoluments received or due and receivable by directors as shown in the

financial statements, or fixed salary of a full-time employee of the Company) by reason of a contract made by the Company

or a related corporation with the director or with a firm of which the director is a member, or with a company in which the

director has a substantial financial interest except for any benefits which may be deemed to arise from transactions entered

into in the ordinary course of business with companies in which certain directors have substantial financial interests as

disclosed in Note 17 to the financial statements.

Neither during nor at the end of the financial year was the Group or the Company a party to any arrangements whose object

is to enable the directors to acquire benefits by means of the acquisition of shares in or debentures of the Company or any

other body corporate.

Directors’ Report

(cont’d)